Related Experiment Video
Updated: May 13, 2026
09:07
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Electroconvulsive therapy for mood disorders in pregnancy.
Mahmut Bulut1, Yasin Bez, Mehmet Cemal Kaya
1Department of Psychiatry, Dicle University School of Medicine, Diyarbakir, Turkey. drmahmutbulut@yahoo.com
The Journal of ECT
|March 23, 2013
Summary
Electroconvulsive therapy (ECT) is a safe and effective treatment for pregnant patients with mood disorders. This study found significant mood improvement with minimal adverse events in 12 women undergoing ECT during pregnancy.
Area of Science:
- Obstetrics and Gynecology
- Psychiatry
- Perinatal Mental Health
Background:
- Mood disorders pose significant risks during pregnancy.
- Treatment options for pregnant individuals with severe mood disorders can be limited.
- Electroconvulsive therapy (ECT) is a recognized treatment for mood disorders.
Purpose of the Study:
- To evaluate the safety and efficacy of electroconvulsive therapy (ECT) for mood disorders in pregnant patients.
- To assess treatment outcomes and adverse events in this specific population.
Main Methods:
- Retrospective examination of 12 pregnant patients treated with ECT for mood disorders.
- Data collection on patient demographics, number of ECT sessions, and clinical outcomes.
- Assessment of mood changes using the Clinical Global Impression (CGI) score.
Main Results:
- Mean age of patients was 28.1 ± 4.8 years.
- Average of 9.8 ± 4.5 ECT sessions were administered.
- Significant reduction in mean CGI scores from 6 to 2.6 ± 0.7.
- One case of early delivery and one case of pes equinovarus deformity were noted, with no clear causal link to ECT.
Conclusions:
- Electroconvulsive therapy (ECT) demonstrates effectiveness in improving mood symptoms in pregnant patients.
- ECT appears to be a safe treatment option for mood disorders during pregnancy, with a low incidence of significant adverse events.
- Further research may be warranted to confirm these findings in larger cohorts.
Related Concept Videos
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...